122 related articles for article (PubMed ID: 35680546)
1. Safety and Feasibility of Contrast-Enhanced Computed Tomography with a Nanoparticle Contrast Agent for Evaluation of Diethylnitrosamine-Induced Liver Tumors in a Rat Model.
Nota T; Kageyama K; Yamamoto A; Kakehashi A; Yonezawa H; Jogo A; Sohgawa E; Murai K; Ogawa S; Miki Y
Acad Radiol; 2023 Jan; 30(1):30-39. PubMed ID: 35680546
[TBL] [Abstract][Full Text] [Related]
2. Time course of contrast enhancement by micro-CT with dedicated contrast agents in normal mice and mice with hepatocellular carcinoma: comparison of one iodinated and two nanoparticle-based agents.
Rothe JH; Rudolph I; Rohwer N; Kupitz D; Gregor-Mamoudou B; Derlin T; Furth C; Amthauer H; Brenner W; Buchert R; Cramer T; Apostolova I
Acad Radiol; 2015 Feb; 22(2):169-78. PubMed ID: 25282584
[TBL] [Abstract][Full Text] [Related]
3. Contrast-enhanced ultrasound LI-RADS 2017: comparison with CT/MRI LI-RADS.
Ding J; Long L; Zhang X; Chen C; Zhou H; Zhou Y; Wang Y; Jing X; Ye Z; Wang F
Eur Radiol; 2021 Feb; 31(2):847-854. PubMed ID: 32803416
[TBL] [Abstract][Full Text] [Related]
4. How to characterize non-hypervascular hepatic nodules on contrast-enhanced computed tomography in chronic liver disease: feasibility of contrast-enhanced ultrasound with a microbubble contrast agent.
Yoshizumi H; Maruyama H; Okugawa H; Kobayashi S; Akiike T; Yoshikawa M; Ebara M; Yokosuka O; Matsutani S; Kondo F; Kamiyama N
J Gastroenterol Hepatol; 2008 Oct; 23(10):1528-34. PubMed ID: 17944882
[TBL] [Abstract][Full Text] [Related]
5. Dietary modulations of folic acid affect the development of diethylnitrosamine induced hepatocellular carcinoma in a rat model.
Sharma R; Ali T; Negi I; Das A; Duseja A; Kaur J
J Mol Histol; 2021 Apr; 52(2):335-350. PubMed ID: 33438102
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in rat models with hepatocellular carcinoma with liver cirrhosis.
Park SI; Lee JH; Ham HJ; Jung YJ; Park MS; Lee J; Maeng LS; Chung YA; Jang KS
Biomed Mater Eng; 2015; 26 Suppl 1():S1669-76. PubMed ID: 26405933
[TBL] [Abstract][Full Text] [Related]
7. Protective effects of Celastrol on diethylnitrosamine-induced hepatocellular carcinoma in rats and its mechanisms.
Chang W; He W; Li PP; Song SS; Yuan PF; Lu JT; Wei W
Eur J Pharmacol; 2016 Aug; 784():173-80. PubMed ID: 27181068
[TBL] [Abstract][Full Text] [Related]
8. Detection and differentiation of early hepatocellular carcinoma from cirrhosis using CT perfusion in a rat liver model.
Li JP; Feng GL; Li DQ; Wang HB; Zhao DL; Wan Y; Jiang HJ
Hepatobiliary Pancreat Dis Int; 2016 Dec; 15(6):612-618. PubMed ID: 27919850
[TBL] [Abstract][Full Text] [Related]
9. Contrast-enhanced micro-computed tomography using ExiTron nano6000 for assessment of liver injury.
Hua XW; Lu TF; Li DW; Wang WG; Li J; Liu ZZ; Lin WW; Zhang JJ; Xia Q
World J Gastroenterol; 2015 Jul; 21(26):8043-51. PubMed ID: 26185375
[TBL] [Abstract][Full Text] [Related]
10. Comparison of international guidelines for diagnosis of hepatocellular carcinoma and implications for transplant allocation in liver transplantation candidates with gadoxetic acid enhanced liver MRI versus contrast enhanced CT: a prospective study with liver explant histopathological correlation.
Odedra D; Jandaghi AB; Bhayana R; Elbanna KY; Espin-Garcia O; Fischer SE; Ghanekar A; Sapisochin G; Jhaveri KS
Cancer Imaging; 2022 Oct; 22(1):55. PubMed ID: 36195953
[TBL] [Abstract][Full Text] [Related]
11. Differences Between CT-Perfusion and Biphasic Contrast-enhanced CT for Detection and Characterization of Hepatocellular Carcinoma: Potential Explanations for Discrepant Cases.
Perl RM; Portugall J; Hinterleitner C; Hinterleitner M; Kloth C; Walter SS; Bitzer M; Horger MS
Anticancer Res; 2021 Mar; 41(3):1451-1458. PubMed ID: 33788737
[TBL] [Abstract][Full Text] [Related]
12. Utility of Contrast-Enhanced Ultrasound for Early Therapeutic Evaluation of Hepatocellular Carcinoma After Transcatheter Arterial Chemoembolization.
Watanabe Y; Ogawa M; Kumagawa M; Hirayama M; Miura T; Matsumoto N; Nakagawara H; Yamamoto T; Moriyama M
J Ultrasound Med; 2020 Mar; 39(3):431-440. PubMed ID: 31436341
[TBL] [Abstract][Full Text] [Related]
13. Detection and characterization of hepatocellular carcinoma in rats with liver cirrhosis: diagnostic value of combined use of MR positive and negative contrast agents.
Guo DM; Qiu TS; Bian J; Liu SF; Wang CZ
Hepatobiliary Pancreat Dis Int; 2009 Feb; 8(1):65-70. PubMed ID: 19208518
[TBL] [Abstract][Full Text] [Related]
14. Attenuation of diethylnitrosamine-induced hepatocellular carcinoma in a rat model by combination therapy of diacerein and gold nanoparticles: a histopathological and immunohistochemical study.
Baokbah TAS
J Histotechnol; 2023 Mar; 46(1):5-16. PubMed ID: 36214360
[TBL] [Abstract][Full Text] [Related]
15. Role of contrast-enhanced ultrasound in follow-up assessment after ablation for hepatocellular carcinoma.
Zheng SG; Xu HX; Lu MD; Xie XY; Xu ZF; Liu GJ; Liu LN
World J Gastroenterol; 2013 Feb; 19(6):855-65. PubMed ID: 23430451
[TBL] [Abstract][Full Text] [Related]
16. Comparison of contrast enhanced ultrasound and contrast enhanced CT or MRI in monitoring percutaneous thermal ablation procedure in patients with hepatocellular carcinoma: a multi-center study in China.
Lu MD; Yu XL; Li AH; Jiang TA; Chen MH; Zhao BZ; Zhou XD; Wang JR
Ultrasound Med Biol; 2007 Nov; 33(11):1736-49. PubMed ID: 17629608
[TBL] [Abstract][Full Text] [Related]
17. N-nitrosodiethylamine-induced pig liver hepatocellular carcinoma model: radiological and histopathological studies.
Li X; Zhou X; Guan Y; Wang YX; Scutt D; Gong QY
Cardiovasc Intervent Radiol; 2006; 29(3):420-8. PubMed ID: 16502159
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of diethylnitrosamine- or hepatitis B virus X gene-induced hepatocellular carcinoma with 18F-FDG PET/CT: a preclinical study.
Park JH; Kang JH; Lee YJ; Kim KI; Lee TS; Kim KM; Park JA; Ko YO; Yu DY; Nahm SS; Jeon TJ; Park YS; Lim SM
Oncol Rep; 2015 Jan; 33(1):347-53. PubMed ID: 25371060
[TBL] [Abstract][Full Text] [Related]
19. Irreversible electroporation of hepatocellular carcinoma: preliminary report on the diagnostic accuracy of magnetic resonance, computer tomography, and contrast-enhanced ultrasound in evaluation of the ablated area.
Granata V; de Lutio di Castelguidone E; Fusco R; Catalano O; Piccirillo M; Palaia R; Izzo F; Gallipoli AD; Petrillo A
Radiol Med; 2016 Feb; 121(2):122-31. PubMed ID: 26345332
[TBL] [Abstract][Full Text] [Related]
20. Contrast-enhanced ultrasound using SonoVue® (sulphur hexafluoride microbubbles) compared with contrast-enhanced computed tomography and contrast-enhanced magnetic resonance imaging for the characterisation of focal liver lesions and detection of liver metastases: a systematic review and cost-effectiveness analysis.
Westwood M; Joore M; Grutters J; Redekop K; Armstrong N; Lee K; Gloy V; Raatz H; Misso K; Severens J; Kleijnen J
Health Technol Assess; 2013 Apr; 17(16):1-243. PubMed ID: 23611316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
